Newsroom
June 17, 2021
Dr. Jason Bowling, Infectious Diseases, and Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities and Ethics, spoke to the San Antonio Express-News about the Delta coronavirus variant being a threat to the unvaccinated, partially vaccinated San Antonians (subscription needed). Read the story.
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.
June 17, 2021
In this video, Dr. Owais Durrani, Emergency Medicine resident physician, discusses the threat of the COVID-19 delta variant in Yahoo! Finance. Watch here.
June 15, 2021
Dr. Jose Cadena Zuluaga, Infectious Diseases, spoke on a Colombia radio program regarding the advantages of Johnson & Johnson’s Janssen vaccine arriving in Colombia. The advantages include that it has only one dose and does not require refrigeration as the other vaccines. Listen here.
June 15, 2021
Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-19 Prevention Network enrolled more than 175 participants. Read the story.
June 15, 2021
Dr. Ruth Berggren, Infectious Diseases, Center for Medical Humanities and Ethics, spoke to KSAT 12 TV audiences on the topic that the COVID-19 vaccine can be taken at the same time as other vaccines, according to the CDC. Watch the story.